1. Home
  2. KRRO

as 08-22-2025 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Founded: 2014 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 147.4M IPO Year: 2019
Target Price: $96.71 AVG Volume (30 days): 128.5K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -9.76 EPS Growth: N/A
52 Week Low/High: $10.29 - $98.00 Next Earning Date: 08-12-2025
Revenue: $6,281,000 Revenue Growth: N/A
Revenue Growth (this year): 65.08% Revenue Growth (next year): -65.30%

KRRO Daily Stock ML Predictions

Share on Social Networks: